Alexion Pharmaceuticals, Inc.

NASDAQ: ALXN
$182.50
+$0.00 (+0.0%)
Closing Price on July 28, 2021

ALXN Articles

The top analyst upgrades, downgrades and initiations seen on Friday morning include Activision Blizzard, Electronic Arts, Transocean, Twitter, Wal-Mart and Yum Brands.
The August 31 short interest data have been compared with the previous report, and short interest decreased for most of these selected biotech stocks.
The August 15 short interest data have been compared with the previous report, and short interest moves were mixed across these selected biotech stocks.
The short interest data are out for the July 29 settlement date and short interest decreased across these selected biotech stocks.
The short interest data are out for the July 15 settlement date. Short interest increased across many of these selected biotech stocks.
The June 30 short interest data have been compared with the previous report, and short interest moves were mixed in these selected biotech stocks.
Credit Suisse has taken a look at which biotech companies in its coverage have the least credit given to pipeline potential at current levels.
Things might have felt bad on Friday’s post-Brexit surprise, but the Dow’s drop of 610 points, a drop of 3.4%, was mild compared to European markets where many of the key stocks were down 10% to...
The short interest data are out for the June 15 settlement date. Biotech companies are considered a riskier group of stocks, with big potential upside and big potential downside. After all, a cure or...
June 22, 2016: Here are four stocks trading with relatively heavy volume among 40 equities making new 52-week lows in Wednesday’s session. NYSE decliners led advancers by 5 to 4 while Nasdaq...
The May 31 short interest data have been compared with the previous report, and short interest moves were mixed in these selected biotech stocks.
The May 13 short interest data have been compared with the previous report, and short interest moves were mixed in these selected biotech stocks.
The short interest data are out for the April 29 settlement date, and short interest moves were mixed in these selected biotech stocks.
With earnings having just been released for some of the top biotech companies, we saw a flurry of analyst calls by the week's end.
The top analyst upgrades, downgrades and initiations seen on Friday morning include Amazon, Ford, Gilead, Level 3, Sarepta, Western Digital and Whiting Petroleum.